Raymond P Roos MD, Editor-in-Chief, is the Marjorie and Robert E Straus Professor of Neurology at the University of Chicago and Associate Chair for Education for the Department of Neurology at University of Chicago Medical Center. Dr. Roos is solely responsible for all aspects of planning of educational activities and has ultimate responsibility for educational content.
View the complete Editorial Board here
Dr. Roos serves on the Scientific Advisory Board of Revalesio Corporation, the Data and Safety Monitoring Board for a clinical trial of a Mallinckrodt Pharmaceuticals product, has received consulting fees from M-T Pharmacy and Best Doctors, and holds shares in Amgen, Merck, Ionis, and GE.
Associate Editors are responsible for recruiting authors and editing all educational content. Their financial disclosures are displayed ahead of specific educational pieces for which they are responsible. Their financial disclosures are also displayed here
Authors are responsible for researching topics assigned to them by an associate editor and writing or updating manuscripts. Their financial disclosures are displayed ahead of specific educational pieces for which they are responsible.
MedLink Corporation does not control educational content. Nevertheless, it does not accept financial support from commercial interests, and none of its managers or other personnel have financial connections with commercial interests.
MedLink Corporation is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
MedLink Corporation designates each MedLink Neurology
internet point-of-care activity for a maximum of 0.5 AMA PRA Category 1 Credit™
. Physicians should claim only the credit commensurate with the extent of their participation in the activity. “AMA PRA Category 1 Credit” is a trademark of the American Medical Association.
MedLink Corporation has been reviewed by the Accreditation Council for Continuing Medical Education (ACCME®) and has been accredited through July of 2019 as a provider of continuing medical education (CME) for physicians. Accreditation in the ACCME System seeks to assure the medical community and the public that MedLink Corporation delivers education that is relevant to clinicians’ needs, evidence-based, evaluated for its effectiveness, and independent of commercial influence.
The ACCME System employs a rigorous process for evaluating institutions' CME programs according to standards that reflect the values of the educator community and aim to accelerate learning, inspire change, and champion improvement in healthcare. Through participation in accredited CME, clinicians and teams drive improvement in their practice and optimize the care, health, and wellness of their patients.
and then earn